Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
May 16 2024 - 3:44PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission File Number: 001-41324
AKANDA
CORP.
(Name of registrant)
1a, 1b Learoyd Road
New Romney TN28 8XU, United Kingdom
(Address of principal
executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
EXHIBIT INDEX
On May 16, 2024, Akanda Corp. (the “Company”)
issued a press release titled “Akanda Corp. Receives Notice Of Non-Compliance From Nasdaq”, a copy of which is furnished herewith
as Exhibit 99.1 to this Report on Form 6-K.
The press release furnished in this report as Exhibit
99.1 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section.
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
AKANDA CORP. |
|
(Registrant) |
|
|
|
Date: May 16, 2024 |
By: |
/s/ Katie Field |
|
|
Name: |
Katie Field |
|
|
Title: |
Interim Chief Executive Officer
and Director |
Exhibit 99.1
AKANDA CORP. RECEIVES NOTICE
OF NON-COMPLIANCE FROM NASDAQ
London, UK May 16, 2024 –Akanda
Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN), announced that
it has received a deficiency notification letter from the Nasdaq Listing Qualifications Department on May 14, 2024, due to non-compliance
with the minimum stockholders’ equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1).
According to Nasdaq’s
listing requirements, companies must maintain a minimum stockholders' equity of $2,500,000. As reported in Akanda’s Form 20-F for
the fiscal year ended December 31, 2023, the Company's stockholders’ equity was reported as ($3,828,892). Akanda currently does
not meet the alternative compliance standards based on market value of listed securities or net income from continuing operations.
Under Nasdaq rules, Akanda has
45 calendar days, or until June 28, 2024, to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, Akanda may
be granted an extension of up to 180 days from the date of the notification letter to evidence compliance.
Akanda is currently evaluating
its options to resolve the deficiency and intends to submit a comprehensive plan to regain compliance within the stipulated timeframe.
The Company will provide updates on its progress as appropriate.
This announcement does not impact
Akanda’s listing on Nasdaq at this time, and its common shares will continue to trade on the Nasdaq Capital Market under the symbol
"AKAN".
Katie Field, Interim Chief Executive
Officer of Akanda, commented, “We are taking immediate steps to address this matter and are focused on actions that will lead to
regaining compliance with Nasdaq’s listing requirements. We appreciate the continued support of our investors during this period.”
This disclosure is being made
in compliance with Nasdaq Listing Rule 5810(b), which requires prompt public disclosure of receipt of a deficiency notification.
About Akanda
Corp.
Akanda
is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to
high quality and affordable products. Akanda's portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor
which supplies pharmacies and clinics within the UK. The Company's seed-to-patient supply chain also includes partnerships Cellen Life
Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK. Akanda
also acquired the right to develop a Canadian farming property in British Columbia, including farming land and related operations and
licenses. The Company plans to develop THC and cannabinoid (CBD) facilities at this site.
Connect
with Akanda: Email | Website | LinkedIn | Twitter | Instagram
Investor
Contact
ir@akandacorp.com
Cautionary Note Regarding Forward-Looking Information
and Statements
This press release contains certain "forward-looking
information" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition,
but instead represent only Akanda's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently
uncertain and outside of Akanda's control. Generally, such forward-looking information or forward-looking statements can be identified
by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected",
"budget", "scheduled", "estimates", "forecasts", "intends", "anticipates"
or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain
actions, events or results "may", "could", "would", "might" or "will be taken", "will
continue", "will occur" or "will be achieved" and similar expressions and include statements regarding the timing
and completion of the proposed offering. Forward-looking information may relate to anticipated events or results including, but not limited
to business strategy, product development and sales and growth plans. The forward-looking information and forward-looking statements contained
in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking information
and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Aug 2023 to Aug 2024